BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1631808)

  • 1. Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism.
    Jude B; Amrouni N; Deguine I; Marey A; Asseman P; Watel A; Thery C; Marache P; Cosson A
    Thromb Res; 1992 Feb; 65(3):457-62. PubMed ID: 1631808
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolism.
    Faivre R; Mirshahi M; Ducellier D; Soria C; Soria J; Mirshahi M; Kieffer Y; Bassand JP; Caen J; Maurat JP
    Thromb Res; 1988 May; 50(4):583-9. PubMed ID: 3413720
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response.
    Deitcher SR; Lucore CL; Eisenberg PR
    Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182
    [No Abstract]   [Full Text] [Related]  

  • 4. Acyl-enzymes as thrombolytic agents in dog models of venous thrombosis and pulmonary embolism.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1984 Apr; 51(2):248-53. PubMed ID: 6234676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late results following fibrinolysis therapy of venous thromboses].
    Breddin HK
    Internist (Berl); 1984 Feb; 25(2):102-7. PubMed ID: 6368451
    [No Abstract]   [Full Text] [Related]  

  • 6. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological surveillance of streptokinase treatment].
    Juhan I; Sampol J; Léonetti J; Mathieu P; Muratore R; Serradimigni A
    Coeur Med Interne; 1978; 17(1):49-55. PubMed ID: 639488
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic therapy for acute deep venous thrombosis: how much is enough?
    Comerota AJ; Katz ML; White JV
    Cardiovasc Surg; 1996 Feb; 4(1):101-4. PubMed ID: 8634837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative study.
    Bell WR
    Thromb Haemost; 1976 Feb; 35(1):57-69. PubMed ID: 785689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on thrombolytic therapy for venous thrombosis in the extremities--dynamics of plasmin inhibitor and FDP following administration of urokinase (author's transl)].
    Takeuchi S; Shiba T
    Nihon Geka Hokan; 1979 May; 48(3):354-61. PubMed ID: 157109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Do thrombolytic agents prevent postphlebitis thromboembolism?].
    Trübestein G
    Haemostasis; 1986; 16 Suppl 4():40-53. PubMed ID: 3490419
    [No Abstract]   [Full Text] [Related]  

  • 13. Current developments in thrombolytic therapy.
    Sherry S
    Thromb Diath Haemorrh Suppl; 1973; 56():201-10. PubMed ID: 4617330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombolytic efficacy of a Lys-plasminogen-urokinase combination: studies in experimental animals and humans].
    Latorre J; Foncuberta J; Rosendo A; Elez J
    Angiologia; 1990; 42(6):218-26. PubMed ID: 2075946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of laboratory tests in the diagnosis of venous thromboembolism.
    Sié P
    Haematologica; 1995; 80(2 Suppl):57-60. PubMed ID: 7628772
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism].
    Peng K; Wang C; Pang BS; Yang YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep; 28(9):596-9. PubMed ID: 16207425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy.
    Bailey A; Lydon JC; Spielman FJ
    Can Anaesth Soc J; 1985 Jul; 32(4):385-9. PubMed ID: 4027765
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for postoperative pulmonary embolism.
    Molina JE; Hunter DW; Yedlicka JW; Cerra FB
    Am J Surg; 1992 Apr; 163(4):375-80; discussion 380-1. PubMed ID: 1558278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolytic treatment of deep venous thrombosis].
    Martínez-Brotons F; Cairols MA
    Sangre (Barc); 1984; 29(4-C):762-6. PubMed ID: 6515512
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of plasma D-dimer in the diagnosis and in the course of fibrinolytic therapy of deep vein thrombosis and pulmonary embolism.
    Knecht MF; Heinrich F; Spanuth E
    Thromb Res; 1992 Jul; 67(2):213-20. PubMed ID: 1440523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.